-- 週三盤前，醫療保健類股漲跌互現，道富醫療保健精選行業SPDR ETF (XLV) 下跌0.6%，而iShares生物科技ETF (IBB) 上漲0.1%。 梯瓦製藥 (TEVA) 股價上漲超過9%，此前該公司公佈了第一季非GAAP利潤和淨收入均高於預期。
Related Articles
Australia
Starbucks Sustains Sales Momentum in April on Better Execution, Morgan Stanley Says
Starbucks (SBUX) sustained its sales momentum in April, driven by ongoing innovation and better execution despite a dynamic macro landscape, Morgan Stanley said in a Wednesday research report.The company's solid Q2 earnings beat was driven by transaction strength with margin beat partly linked to accounting in the China deal, but North America margins continue to face pressure, analysts wrote.The brokerage raised its Q3 and Q4 comp forecast to 5.7% and 4.7%, respectively. For Q3, it expects EPS of $0.63 and $0.67 for Q4. For the full-year 2026, Morgan Stanley now expects EPS of $2.37 from $2.27 earlier.Operations, staffing, innovation, marketing, and improving the asset base appear to be driving compounding benefits alongside the impacts from cost actions, according to the note.The brokerage said it reiterated its overweight rating on the stock and boosted its price target to $110 per share from $105 earlier.Price: $104.81, Change: $+7.53, Percent Change: +7.74%
$SBUX
Australia
Rothschild & Co Redburn Adjusts GE Vernova Price Target to $1,200 From $1,100, Maintains Buy Rating
GE Vernova (GEV) has an average rating of overweight and mean price target of $1,190.40, according to analysts polled by FactSet.Price: $1068.97, Change: $-19.97, Percent Change: -1.83%
$GEV
Australia
Wells Fargo Adjusts Price Target on PACCAR to $125 From $119, Maintains Equalweight Rating
PACCAR Inc (PCAR) has an average rating of hold and mean price target of $129.70, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $119.82, Change: $+0.21, Percent Change: +0.18%
$PCAR